Finger-prick autologous blood eye drops for dry eye disease
Quantitative & qualitative efficacy of finger-prick autologous blood eye drops versus conventional medical therapy for the treatment of severe dry eye disease.
Source: dovepress.com
Page 6 - Ocular Surface News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ocular Surface. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ocular Surface Today - Breaking & Trending Today
Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Administration for Reproxalap for the Treatment of Signs and Symptoms of Dry Eye Disease
Aldeyra Therapeutics, Inc. today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for topical ocular reproxalap, an investigational new drug candidate,... | November 29, 2022
Source: marketscreener.com
OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease
Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology bio-pharmaceutical
Source: finanznachrichten.de
Investegate |OKYO Pharma LTD Announcements | OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease
Investegate announcements from OKYO Pharma LTD, OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease
Source: investegate.co.uk
OKYO Pharma Hosting Key Opinion Leader Event Introducing
Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO)...
Source: globenewswire.com